Consistency of effect of ezetimibe/simvastatin compared with intensified lipid-lowering treatment strategies in obese and non-obese diabetic subjects

Autor: Mary E. Hanson, Jose G Jimenez, Hella Vides, Joseph Triscari, Rachid Massaad, Jeffery B. Rosen, Valdis Pirags, Philippe Brudi
Rok vydání: 2013
Předmět:
Male
Simvastatin
Apolipoprotein B
Endocrinology
Diabetes and Metabolism
Atorvastatin
Clinical Biochemistry
chemistry.chemical_compound
Endocrinology
Rosuvastatin Calcium
Sulfonamides
Nutrition and Dietetics
biology
Anticholesteremic Agents
Diabetes
Middle Aged
Treatment Outcome
Female
lipids (amino acids
peptides
and proteins)
Cardiology and Cardiovascular Medicine
medicine.drug
Adult
medicine.medical_specialty
Statin
Adolescent
medicine.drug_class
Urology
Rosuvastatin
Young Adult
Ezetimibe
Diabetes mellitus
Internal medicine
Internal Medicine
medicine
Humans
Pyrroles
Obesity
cardiovascular diseases
Aged
Apolipoproteins B
Biochemistry
medical
Cholesterol
business.industry
Research
Biochemistry (medical)
nutritional and metabolic diseases
Cholesterol
LDL
medicine.disease
Peptide Fragments
Fluorobenzenes
Diabetes Mellitus
Type 1
Pyrimidines
Diabetes Mellitus
Type 2
chemistry
Heptanoic Acids
biology.protein
Azetidines
Ezetimibe/simvastatin
business
Zdroj: Lipids in Health and Disease
ISSN: 1476-511X
Popis: Purpose: This post hoc analysis assessed switching to ezetimibe/simvastatin 10/20 mg vs doubling the baseline statin dose to simvastatin 40 mg or atorvastatin 20 mg or switching to rosuvastatin 10 mg in subgroups of obese (BMI ≥30 kg/m 2 ) and non-obese (BMI
Databáze: OpenAIRE
Externí odkaz: